Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-13Clinical Trial Update: Lung Cancer Screening CT for Firefighters [NA]
A clinical trial evaluating CT-based lung cancer screening for firefighters has been withdrawn, according to the sponsor University of Calif…
-
CLINICAL_TRIALS withdrawal · 2025-07-29Clinical Trial Update: Identification of Novel Markers of Human Lung Disease
The Ohio State University-sponsored trial 'Identification of Novel Markers of Human Lung Disease' evaluating interstitial lung diseases has …
-
CLINICAL_TRIALS withdrawal · 2025-02-20Clinical Trial Update: CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating comprehensive phenotypic characterization of patients with scleroderma-associated interstitial lung disea…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating inhaled nitric oxide for dyspnea and exercise tolerance in interstitial lung disease has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2018-05-01Clinical Trial Update: Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil [Phase 4]
Phase 4 trial evaluating sildenafil for pulmonary hypertension associated with idiopathic pulmonary fibrosis was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.